RMTG Q2 Revenue Soars 309% but Going Concern and Debt Defaults Persist
RMTG has more than doubled off its 52-week low of $0.019.
Summary
RMTG reported explosive revenue growth and an operating profit, but the going concern warning, debt defaults, and massive dilution overhang keep the risk profile elevated.
Key Events · Earnings and Guidance · RMTG
-
Revenue Surges 309%
Q2 2026 revenue hit $4,022,763, up from $983,318 a year ago, driven by training, product supplies, and patient procedures.
-
Operating Profit Achieved
Income from operations was $565,977 for Q2, a swing from a $250,087 loss last year, but net loss remained $2.9 million due to interest and derivative charges.
-
Going Concern Warning Reiterated
Accumulated deficit of $79.5 million and working capital deficit of $40.3 million raise substantial doubt about the company's ability to continue.
-
Debt Defaults and Acceleration Risk
Multiple promissory notes are in default, and a formal demand could trigger acceleration of up to $16.6 million in secured debt.
Analysis · RMTG · Trade & Services
Revenue exploded to $4.02 million in Q2, up 309% year-over-year, and the company swung to an operating profit of $565,977. But the balance sheet remains precarious: a $40.3 million working capital deficit, $19.6 million in accrued interest, multiple notes in default, and a going concern warning. The company also issued three new convertible notes after quarter end totaling $497,000, adding to dilution risk. The recent PRE 14C to quadruple authorized shares to 400 million underscores the massive overhang from warrants and convertible securities.
At the time of this filing, RMTG was trading at $0.06 on OTC in the Trade & Services sector, with a market capitalization of approximately $784.4K. The 52-week trading range was $0.02 to $0.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.